JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Search results for: 'signaling pathways cardiovascular {{media url='

Search results for: 'signaling pathways cardiovascular {{media url='

A3724 PI-103 Hydrochloride

Target: PI3K|mTOR|DNA-PK

Summary: DNA-PK/PI 3-kinase/mTOR inhibitor

insoluble in H2O; insoluble in EtOH; ≥19.25 mg/mL
A3927 VS-5584 (SB2343)

Target: PI3K|mTOR

Summary: MTOR/P13K inhibitor,potent and selective

insoluble in H2O; ≥17.7 mg/mL
A8213 KY 02111

Summary: WNT signaling inhibitor

insoluble in H2O; ≥18.85 mg/mL
A3413 FH535

Summary: Wnt/B-catenin inhibitor

≥36.1 mg/mL
A4529 JW 55

Summary: PARP domain inhibitor

insoluble in H2O; ≥19.25 mg/mL
A8685 Wnt-C59
2 Citation

Target: PORCN

Summary: PORCN inhibitor,highly potent and selective

.95 mg/mL

insoluble in H2O; ≥18
A3512 IWP-2
2 Citation

Summary: Wnt production inhibitor,PORCN inhibitor

≥23.35 mg/mL
A3785 Salinomycin

Target: Antibiotic

Summary: Polyether ionophore antibiotic;anti-cancer
A1632 SB202190 (FHPI)
5 Citation

Target: p38

Summary: P38 MAPK inhibitor
A8396 CHIR-99021 (CT99021) HCl

Target: GSK-3

Summary: GSK-3α/β inhibitor

≥25.1 mg/mL